Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC reduced its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,464,887 shares of the company's stock after selling 13,662 shares during the quarter. Janus Henderson Group PLC owned about 1.33% of Doximity worth $107,395,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its stake in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Blue Trust Inc. raised its stake in Doximity by 621.4% in the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock valued at $37,000 after purchasing an additional 1,193 shares during the last quarter. GAMMA Investing LLC raised its stake in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock valued at $63,000 after purchasing an additional 412 shares during the last quarter. Quarry LP raised its stake in Doximity by 101.2% in the 2nd quarter. Quarry LP now owns 1,616 shares of the company's stock valued at $45,000 after purchasing an additional 131,253 shares during the last quarter. Finally, Covestor Ltd increased its stake in shares of Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company's stock worth $73,000 after acquiring an additional 1,370 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Stock Performance

DOCS stock traded up $1.12 during mid-day trading on Thursday, reaching $55.32. The company had a trading volume of 1,442,359 shares, compared to its average volume of 1,755,483. The company has a market capitalization of $10.33 billion, a price-to-earnings ratio of 63.53, a price-to-earnings-growth ratio of 4.34 and a beta of 1.40. The firm has a fifty day simple moving average of $46.60 and a 200 day simple moving average of $36.69. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. JPMorgan Chase & Co. raised their target price on Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. KeyCorp raised Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 target price for the company in a research note on Friday, November 8th. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $60.00 target price (up from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Mizuho assumed coverage on Doximity in a research note on Wednesday. They issued a "neutral" rating and a $55.00 target price for the company. Finally, Robert W. Baird raised their target price on Doximity from $41.00 to $45.00 and gave the stock an "outperform" rating in a research note on Tuesday, September 17th. Twelve analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $52.44.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.